MAPT and Alzheimer disease: In addition, CI individuals (MCI or dementia) had abnormal changes in plasma Aβ42/Aβ40, p-Tau181, and NfL, and Aβ PET, tau PET, hippocampal volume, and AD-signature cortical thickness compared to the CU (NC or SCD) individuals.